The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 09, 2022
Filed:
Jul. 21, 2020
Applicant:
Nicox Ophthalmics, Inc., Durham, NC (US);
Inventors:
Jean-Michel Bukowski, Villeneuve Leubet, FR;
Akshay Nadkarni, Cary, NC (US);
José L. Boyer, Chapel Hill, NC (US);
Brigitte Duquesroix-Chakroun, Cagnes sur Mer, FR;
Tomas Navratil, Durham, NC (US);
Assignee:
NICOX OPHTHALMICS, INC., Durham, NC (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/08 (2006.01); A61P 27/02 (2006.01); A61K 9/00 (2006.01); A61K 31/567 (2006.01); A61K 47/02 (2006.01); A61K 47/10 (2017.01); A61K 47/18 (2017.01); A61K 47/26 (2006.01); A61K 47/38 (2006.01); B82Y 5/00 (2011.01);
U.S. Cl.
CPC ...
A61K 9/08 (2013.01); A61K 9/0048 (2013.01); A61K 31/567 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/183 (2013.01); A61K 47/186 (2013.01); A61K 47/26 (2013.01); A61K 47/38 (2013.01); A61P 27/02 (2018.01); B82Y 5/00 (2013.01);
Abstract
A process of manufacturing sterile topical ophthalmic aqueous nanosuspensions of nanocrystals of fluticasone propionate Form A. The sterile topical ophthalmic nanosuspensions may be used in the treatment of eye inflammation conditions such as blepharitis, posterior blepharitis, Meibomian gland dysfunction and dry eye through topical administration of said nanosuspensions to eyelids, eyelashes and eyelid margin.